EA200000282A1 - Способ введения таксана пациенту, нуждающемуся в лечении таксаном, способ лечения человека таксаном (варианты) - Google Patents

Способ введения таксана пациенту, нуждающемуся в лечении таксаном, способ лечения человека таксаном (варианты)

Info

Publication number
EA200000282A1
EA200000282A1 EA200000282A EA200000282A EA200000282A1 EA 200000282 A1 EA200000282 A1 EA 200000282A1 EA 200000282 A EA200000282 A EA 200000282A EA 200000282 A EA200000282 A EA 200000282A EA 200000282 A1 EA200000282 A1 EA 200000282A1
Authority
EA
Eurasian Patent Office
Prior art keywords
taxan
patient
taksana
introduction
treating
Prior art date
Application number
EA200000282A
Other languages
English (en)
Other versions
EA003678B1 (ru
Inventor
Аквилар Рахман
Original Assignee
Неофарм
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Неофарм filed Critical Неофарм
Publication of EA200000282A1 publication Critical patent/EA200000282A1/ru
Publication of EA003678B1 publication Critical patent/EA003678B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Предложены инкапсулированный в липосомы таксан или его противоопухолевое производное или их смесь, которые используют для осуществления терапевтически более эффективного метода лечения рака. Инкапсулированный в липосомы паклитаксел пригоден для введения пациенту, в частности пациенту-человеку, в течение менее чем одного часа без проявления существенной токсичности.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200000282A 1998-07-01 1999-06-29 Способ введения таксана пациенту, нуждающемуся в лечении таксаном, способ лечения человека таксаном EA003678B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/108,509 US6146659A (en) 1998-07-01 1998-07-01 Method of administering liposomal encapsulated taxane
PCT/US1999/014986 WO2000001366A1 (en) 1998-07-01 1999-06-29 A method of administering liposomal encapsulated taxane

Publications (2)

Publication Number Publication Date
EA200000282A1 true EA200000282A1 (ru) 2000-10-30
EA003678B1 EA003678B1 (ru) 2003-08-28

Family

ID=22322617

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000282A EA003678B1 (ru) 1998-07-01 1999-06-29 Способ введения таксана пациенту, нуждающемуся в лечении таксаном, способ лечения человека таксаном

Country Status (17)

Country Link
US (1) US6146659A (ru)
EP (1) EP1009384A4 (ru)
JP (2) JP2001524990A (ru)
KR (1) KR20010023522A (ru)
CN (1) CN1275076A (ru)
AU (1) AU730599B2 (ru)
BR (1) BR9906581A (ru)
CA (1) CA2301057C (ru)
EA (1) EA003678B1 (ru)
HU (1) HUP0004583A3 (ru)
IL (1) IL134747A0 (ru)
NO (1) NO20001012L (ru)
NZ (1) NZ524490A (ru)
PL (1) PL338951A1 (ru)
SK (1) SK4642000A3 (ru)
TR (1) TR200000576T1 (ru)
WO (1) WO2000001366A1 (ru)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030087954A1 (en) * 1997-01-07 2003-05-08 Sonus Pharmaceuticals, Inc. Method of treating bladder carcinoma using a Taxane/Tocopherol formulation
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7112338B2 (en) * 1997-03-12 2006-09-26 The Regents Of The University Of California Cationic liposome delivery of taxanes to angiogenic blood vessels
US7262173B2 (en) * 1997-03-21 2007-08-28 Georgetown University Chemosensitizing with liposomes containing oligonucleotides
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US7314637B1 (en) * 1999-06-29 2008-01-01 Neopharm, Inc. Method of administering liposomal encapsulated taxane
US6461637B1 (en) * 2000-09-01 2002-10-08 Neopharm, Inc. Method of administering liposomal encapsulated taxane
US6835721B2 (en) * 1999-02-01 2004-12-28 Eisai Co., Ltd. Immunomodulatory compounds and methods of use thereof
US20040006242A1 (en) * 1999-02-01 2004-01-08 Hawkins Lynn D. Immunomodulatory compounds and method of use thereof
US7915238B2 (en) * 1999-02-01 2011-03-29 Eisai R & D Management Co., Ltd. Immunomodulatory compounds and methods of use thereof
USRE43914E1 (en) * 1999-06-09 2013-01-08 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Method for detecting syphilis using synthetic antigens
AU782714B2 (en) * 1999-09-09 2005-08-25 Regents Of The University Of California, The Cationic liposome delivery of taxanes to angiogenic blood vessels
AR030188A1 (es) 2000-02-02 2003-08-13 Univ Florida State Res Found Compuestos de taxano sustituidos con esteres en el c7; composiciones farmaceuticas que los contienen y proceso para tratar un sujeto mamifero que sufre de una condicion que responde a los taxanos
JP4786105B2 (ja) * 2000-02-04 2011-10-05 リポクセン テクノロジーズ リミテッド リポソーム
US20030133972A1 (en) * 2000-10-11 2003-07-17 Targesome, Inc. Targeted multivalent macromolecules
US20030129223A1 (en) * 2000-10-11 2003-07-10 Targesome, Inc. Targeted multivalent macromolecules
KR100869824B1 (ko) 2000-11-09 2008-11-21 네오팜 인코포레이티드 Ｓｎ-38 지질 복합체 및 사용 방법
US20020073441A1 (en) 2000-12-13 2002-06-13 Ross Brian D. Compositions and methods for detecting proteolytic activity
WO2003030864A1 (en) * 2001-05-29 2003-04-17 Neopharm, Inc. Liposomal formulation of irinotecan
CA2354486A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C7 ester substituted taxanes
WO2003018018A2 (en) * 2001-08-24 2003-03-06 Neopharm, Inc. Vinorelbine compositions and methods of use
DE10154464B4 (de) * 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
EA200400658A1 (ru) * 2001-11-09 2004-10-28 Неофарм, Инк. Способ лечения опухолей, экспрессирующих рецептор для ил-13 (варианты)
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
US20030180348A1 (en) * 2002-03-22 2003-09-25 Levinson R. Saul Transcellular drug delivery system
US7138512B2 (en) * 2002-04-10 2006-11-21 Georgetown University Gene SHINC-2 and diagnostic and therapeutic uses thereof
CN100341589C (zh) 2002-05-24 2007-10-10 血管技术国际股份公司 用于涂覆医用植入物的组合物和方法
US20050153297A1 (en) * 2002-05-29 2005-07-14 Ateeq Ahmad Method for determining oligonucleotide concentration
CA2491312C (en) * 2002-07-15 2011-05-31 Alcon, Inc. Bioerodible film for ophthalmic drug delivery
KR100533458B1 (ko) * 2002-07-20 2005-12-07 대화제약 주식회사 파클리탁셀의 가용화용 조성물 및 그의 제조 방법
AU2003268087A1 (en) * 2002-08-23 2004-03-11 Ian Ma Liposomal gemcitabine compositions for better drug delivery
EA200501252A1 (ru) * 2003-02-03 2006-02-24 Неофарм, Инк. Липосомальная композиция, способ ее получения и лекарственное средство на ее основе (варианты)
EP1613284A2 (en) * 2003-02-11 2006-01-11 Neopharm, Inc. Manufacturing process for liposomal preparations
WO2004087758A2 (en) * 2003-03-26 2004-10-14 Neopharm, Inc. Il 13 receptor alpha 2 antibody and methods of use
WO2005000266A2 (en) * 2003-05-22 2005-01-06 Neopharm, Inc. Liposomal formulations comprising a combination of two or more active agents
US20060078560A1 (en) * 2003-06-23 2006-04-13 Neopharm, Inc. Method of inducing apoptosis and inhibiting cardiolipin synthesis
DK2286794T3 (en) 2003-10-15 2016-07-25 Syncore Biotechnology Co Ltd USE OF CATIONIC LIPOSOMES, WHICH INCLUDES paclitaxel
AR048078A1 (es) 2004-03-05 2006-03-29 Univ Florida State Res Found Taxanos con sustituyente lactiloxilo en el c7
PT1744764E (pt) * 2004-04-22 2012-08-30 Celator Pharmaceuticals Inc Formulações lipossómicas de agentes antraciclina e análogos de citidina
JP4433918B2 (ja) * 2004-07-15 2010-03-17 コニカミノルタエムジー株式会社 画像形成方法
CA2585972A1 (en) * 2004-10-29 2006-05-11 Neopharm, Inc. Manufacturing process for liposomal preparations
CN101217946B (zh) 2004-11-02 2012-11-07 特拉维夫大学未来技术研发有限公司 水不溶性的或低水溶性药物在脂质化糖胺聚糖颗粒中的制剂和它们的制药用途
KR100651728B1 (ko) * 2004-11-10 2006-12-06 한국전자통신연구원 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
US20070292418A1 (en) * 2005-04-26 2007-12-20 Eisai Co., Ltd. Compositions and methods for immunotherapy
EP1874342B1 (en) 2005-04-26 2018-06-06 Eisai R&D Management Co., Ltd. Compositions and methods for cancer immunotherapy
US9233094B2 (en) 2005-05-04 2016-01-12 Medigene Ag Method of administering a cationic liposomal preparation
CA2922029C (en) 2006-03-22 2017-11-28 Medigene Ag A combination of a cationic liposomal preparation comprising an antimitotic agent and a non-liposomal preparation comprising an antimitotic agent
EA200802166A1 (ru) 2006-04-20 2009-06-30 Эмджен Инк. Стабильная фармацевтическая композиция с защитным действием от раздражения (варианты), способ ее получения и способ лечения кальций-миметиком с ее помощью
US9637515B2 (en) 2006-11-06 2017-05-02 Jina Pharmaceuticals, Inc. Guggulphospholipid methods and compositions
GB0905348D0 (en) * 2009-03-27 2009-05-13 Ucl Business Plc Carrier
WO2011038073A1 (en) 2009-09-23 2011-03-31 Formatech, Inc. Methods for the preparation of liposomes comprising docetaxel
US20110070294A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Administration of Drugs Using Liposomes
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
PL226015B1 (pl) * 2011-03-03 2017-06-30 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna
AU2013360302C1 (en) 2012-12-12 2019-01-24 Temple University - Of The Commonwealth System Of Higher Education Compositions and methods for treatment of cancer
US20160128971A1 (en) * 2013-04-05 2016-05-12 Vuong Trieu Nanoparticle Compositions
JP2016530331A (ja) * 2013-09-13 2016-09-29 アーバー・セラピューティクス・リミテッド・ライアビリティ・カンパニーＡｒｂｏｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，ＬＬＣ 癌化学療法剤の酸不安定、親油性プロドラッグの標的化送達用ナノ粒子組成物およびそれらの製造

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
US4812314A (en) * 1986-02-24 1989-03-14 Yissum Research & Dev. Co. Of The Hebrew Univ. Of Jerusalem And Hadassah Medical Organization Lipid replacement therapy
US4927571A (en) * 1987-05-18 1990-05-22 Liposome Technology, Inc. Preparation of injectable doxorubicin/liposome suspension
WO1993018751A1 (en) * 1992-03-23 1993-09-30 Georgetown University Liposome encapsulated taxol and a method of using the same
WO1994026254A1 (en) * 1993-05-17 1994-11-24 The Liposome Company, Inc. Incorporation of taxol into liposomes and gels
JPH06329533A (ja) * 1993-05-20 1994-11-29 Kyowa Hakko Kogyo Co Ltd リポソーム製剤の製造法
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
DE4430593C2 (de) * 1994-08-20 1999-01-14 Max Delbrueck Centrum Verfahren zur Herstellung von Liposomal verkapseltem Taxol
CA2205500A1 (en) * 1994-11-18 1996-05-30 Aphios Corporation Methods and apparatus for making liposomes containing hydrophobic drugs
US5580899A (en) * 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives
ES2179208T3 (es) * 1995-09-12 2003-01-16 Elan Pharm Inc Derivados hidrofobos de taxano que favorecen la hidrolisis.
CA2189916C (en) * 1996-11-08 2001-01-16 Parkash S. Gill A new regime for paclitaxel in kaposi's sarcoma patients

Also Published As

Publication number Publication date
IL134747A0 (en) 2001-04-30
WO2000001366A1 (en) 2000-01-13
EA003678B1 (ru) 2003-08-28
BR9906581A (pt) 2000-09-26
EP1009384A4 (en) 2004-11-17
KR20010023522A (ko) 2001-03-26
HUP0004583A2 (hu) 2001-08-28
TR200000576T1 (tr) 2000-11-21
EP1009384A1 (en) 2000-06-21
AU5088099A (en) 2000-01-24
CN1275076A (zh) 2000-11-29
NO20001012L (no) 2000-03-15
JP2001524990A (ja) 2001-12-04
NZ524490A (en) 2005-04-29
NO20001012D0 (no) 2000-02-29
CA2301057A1 (en) 2000-01-13
AU730599B2 (en) 2001-03-08
CA2301057C (en) 2009-03-10
JP2004059590A (ja) 2004-02-26
US6146659A (en) 2000-11-14
SK4642000A3 (en) 2000-11-07
PL338951A1 (en) 2000-12-04
HUP0004583A3 (en) 2002-04-29

Similar Documents

Publication Publication Date Title
EA200000282A1 (ru) Способ введения таксана пациенту, нуждающемуся в лечении таксаном, способ лечения человека таксаном (варианты)
DE60234577D1 (de) Pharmazeutische mischung zur behandlung von krebs, die dioxolan nukleosidanalogen enthält
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
EP1039887A4 (en) PROCESS FOR THE TREATMENT OF NEURO AND NEPHROTOXICITIES AND THERAPEUTIC TOXICITIES WITH AMINOTHIOL COMPOUNDS
ATE219363T1 (de) Lösliche prodrugs von paclitaxel
WO2004006842A3 (en) Combinations of drugs for the treatment of neoplasms
WO2002058694A3 (en) Method of treating hematologic tumors and cancers using beta lapachone
DE69834923D1 (en) Hochgradig lipophile camptothecin-derivate
DE69731652D1 (de) Verfahren zur behandlung von endothelialen verletzungen
ATE432923T1 (de) 5-aminoindenoä1,2-cüpyrazol-4-one als antitumor- und wachstumshemmende mittel
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
FI955424A (fi) Syklodekstriinien kanssa muodostettuja taksoli- ja taksoteeri- tai Taxus-uuteinkluusiokomplekseja ja niiden valmistus ja käyttö
DE69824313D1 (de) Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen
TR200402230T4 (tr) O-ikameli 6-metil-tramadol-türevleri
ATE241376T1 (de) Zusammensetzungen, die dolastatin-15-analoge in kombination mit taxane und dessen derivaten enthalten
MY135460A (en) Method of stimulating hair growth using benzopyrans
DE60104281D1 (de) Semi-synthetische taxane mit antitumor und antiangiogenetischer wirkung
MX9706283A (es) Nuevos antibioticos de polieno, 3874 hi a h6, procedimientos para su preparacion y empleo.
MX9200755A (es) Tratamiento de carcinoma pulmonar de celulas no pequeñas.
TR200000728T2 (tr) Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı.
DK0659079T3 (da) Transdermalt terapeutisk system med pentylentetrazol som aktivt stof.
UA36093A (ru) Способ лечения хронического бронхита
MXPA05008879A (es) Una terapia combinada que comprende un derivado de indolopirrolocarbazol y otro agente antitumoral.
UA30359A (ru) Способ лечения гнойных ран

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM